Weiter zum Inhalt
Toggle navigation
English
English
Favoritenliste (
0
)
(Voll)
Kontakt
Mein Konto
Abmeldung
Mein Konto
Suche
Filter bei nächster Suche beibehalten
topic_facet:"Lymphoma"
format_facet:"Elektronische Aufsätze"
Erweiterte Suche
Suchverlauf
Struktursuche
Narrative Service
Drug Overviews
Info Guide
/vufind/Search/Results?filter%5B%5D=topic_facet%3A%22Lymphoma%22&filter%5B%5D=format_facet%3A%22Elektronische+Aufs%C3%A4tze%22&lookfor=%22ClinicalTrials.gov%22&type=JournalTitle
/vufind/Search/Results?filter%5B%5D=topic_facet%3A%22Lymphoma%22&filter%5B%5D=format_facet%3A%22Elektronische+Aufs%C3%A4tze%22&lookfor=%22ClinicalTrials.gov%22&type=JournalTitle
Search /vufind/Search2/Results?filter%5B%5D=topic_facet%3A%22Lymphoma%22&filter%5B%5D=format_facet%3A%22Elektronische+Aufs%C3%A4tze%22&lookfor=%22ClinicalTrials.gov%22&type=JournalTitle
PubPharm (5.675)
1
Specimen Collections From Participants With HIV Infection, KSHV Infection, Viral-Related Pre-malignant Lesions and Cancer : Collection of Blood, Bone Marrow, Tumor, or Tissue Samples From Patients With HIV Infection, KSHV Infection, Viral-Related Pre-Malignant Lesions, and/or Cancer
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
2
Administration of Anti-CD19-chimeric-antigen-receptor-transduced T Cells From the Original Transplant Donor to Patients With Recurrent or Persistent B-cell Malignancies After Allogeneic Stem Cell Transplantation : Administration of Anti-CD19-Chimeric-Antigen-Receptor-Transduced T Cells From the Original Transplant Donor to Patients With Recurrent or Persistent B-Cell Malignancies After Allogeneic Stem Cell Transplantation
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
3
Brentuximab Vedotin and Combination Chemotherapy in Treating Patients With Stage II-IV HIV-Associated Hodgkin Lymphoma : A Pilot Trial of AVD and Brentuximab Vedotin (SGN-35) in the Treatment of Stage II-IV HIV-Associated Hodgkin Lymphoma
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
4
Rituximab and Combination Chemotherapy With or Without Lenalidomide in Treating Patients With Newly Diagnosed Stage II-IV Diffuse Large B Cell Lymphoma : Randomized Phase II Open Label Study of Lenalidomide R-CHOP (R2CHOP) vs. RCHOP (Rituximab, Cyclophosphamide, Doxorubicin, Vincristine and Prednisone) in Patients With Newly Diagnosed Diffuse Large B Cell Lymphoma
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
5
Brentuximab Vedotin or Crizotinib and Combination Chemotherapy in Treating Patients With Newly Diagnosed Stage II-IV Anaplastic Large Cell Lymphoma : A Randomized Phase 2 Trial of Brentuximab Vedotin (SGN35, NSC# 749710), or Crizotinib (NSC#749005, Commercially Labeled) in Combination With Chemotherapy for Newly Diagnosed Patients With Anaplastic Large Cell Lymphoma (ALCL)
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
6
Study of Palifermin (Kepivance) in Persons Undergoing Unrelated Donor Allogeneic Hematopoietic Cell Transplantation : A Phase I/II Open Label, Dose Escalation Study of Palifermin (Kepivance) in Persons Undergoing Unrelated Donor Allogeneic Hematopoietic Cell Transplantation
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
7
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial) : Molecular Analysis for Therapy Choice (MATCH)
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
8
Targeted Therapy Directed by Genetic Testing in Treating Pediatric Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphomas, or Histiocytic Disorders (The Pediatric MATCH Screening Trial) : NCI-COG Pediatric MATCH (Molecular Analysis for Therapy Choice) Screening Protocol
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
9
Ensartinib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With ALK or ROS1 Genomic Alterations (A Pediatric MATCH Treatment Trial) : NCI-COG Pediatric MATCH (Molecular Analysis for Therapy Choice)- Phase 2 Subprotocol of Ensartinib in Patients With Tumors Harboring ALK or ROS1 Genomic Alterations
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
10
A Study Comparing Obinutuzumab and BGB-3111 Versus Obinutuzumab Alone in Treating R/R Follicular Lymphoma : An International, Phase 2, Open-Label, Randomized Study of BGB-3111 Combined With Obinutuzumab Compared With Obinutuzumab Monotherapy in Relapsed/ Refractory Follicular Lymphoma
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
1
2
3
4
5
6
7
8
9
10
11
Nächster »
[568]
Filter & Sortierung
Treffer pro Seite
10
20
50
Sortieren
Relevanz
Neueste zuerst
Älteste zuerst
Verfasser
Zeitschriftentitel
Bibliothek
Standort (Printmedien)
Verwandte Substanzen
Verwandte Substanzen werden ermittelt...
Verwandte Erkrankungen/Symptome
Verwandte Erkrankungen/Symptome werden ermittelt...
Verwandte Gene
Verwandte Gene werden ermittelt...
Systematic Reviews
Clinical Studies
Patente
Covid-19/SARS-CoV-2
Exclude Systematic Reviews
Exclude Clinical Studies
Exclude Patents
Ihre gewählten Filter
Filter bei nächster Suche beibehalten
Filter aufheben
Alle gewählten Filter entfernen
Filter aufheben
Thema: Lymphoma
Filter aufheben
Medienart: E-Artikel
Medienart
5.675
Aufsätze
E-Artikel
5.675
E-Ressourcen
Zeitschriftentitel
5.675
ClinicalTrials.gov
Thema
5.675
610
Lymphoma
5.020
Study Type: Interventional
1.991
Recruitment Status: Completed
1.947
Phase: Phase 2
1.554
Lymphoma, Non-Hodgkin
1.478
Lymphoma, B-Cell
1.459
Recruitment Status: Recruiting
1.353
Phase: Phase 1
1.150
Lymphoma, Large B-Cell, Diffuse
1.006
Leukemia
725
Recruitment Status: Active, not recruiting
663
Lymphoma, T-Cell
658
Lymphoma, Mantle-Cell
657
Leukemia, Lymphocytic, Chronic, B-Cell
638
Leukemia, Lymphoid
617
Hodgkin Disease
607
Study Type: Observational
597
Lymphoma, Follicular
578
Recruitment Status: Terminated
Alle anzeigen ...
weniger ...
Erscheinungszeitraum
3.703
2020-
1.891
2010-2019
81
2000-2009
Erscheinungsjahr(e)
Von:
Bis:
Sprache
5.675
Englisch
Haven't found what you're looking for?
Wird geladen...